Il-Jin Kim, PhD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Il-Jin Kim, PhD

Assistant Professor, Department of Surgery, University of California at San Francisco

kimij@cc.ucsf.edu

Phone: (415) 502-6791

View on UCSF Profiles

Cancer Center Membership

Associate Member ยป Non-aligned

Research Summary

Journal Editor.

2012-present: ISRN Biotechnology,

2013-present: Journal of Surgery

Education

College of Veterinary Medicine, Seoul National University, Korea,    B.S., D.V.M.,    1999,    Veterinary Medicine
College of Medicine, Seoul National University, Korea,    M.S.,    2001,    Tumor Biology
College of Medicine, Seoul National University, Korea,    Ph.D.,    2003,    Tumor Biology
College of Medicine, Seoul National University, Korea,    Post-doc,    2003-2006,    Cancer Genetics
Cancer Research Institute, University of California San Francisco,       Post-doc,    2007-2008,    Cancer Genetics
 


Professional Experience

  • 3/2008-6/2010
    Assistant Research Geneticist, Cancer Research Institute, University of California at San Francisco, USA
  • 7/2010-present
    Assistant Professor (Full-time), Department of Surgery, University of California at San Francisco, USA
  • 2011-present
    Director, Applied Genomics, Thoracic Oncology Program, University of California at San Francisco, USA

Honors & Awards

  • 1999
    Graduation with Honors (Cum Laude), Seoul National University, Korea

  • 2002
    Best Research Award, Korea Cancer Research Foundation, Korea

  • 2003
    AACR ITO-EN Scholar-In-Training Award, American Association for Cancer Research, USA

  • 2003
    Best Research Award, Korea Cancer Research Foundation, Korea

  • 2003-2004
    BK21 (Brain Korea 21) Postdoctoral Fellowship, Korea

  • 2004
    Best Research Award, Korea Cancer Research Foundation, Korea

  • 2004
    Outstanding Science and Technology Publication Award, Korean Federation of Science and Technology Societies, Korea

  • 2004
    National Cancer Center Travel Award to AACR annual meeting, Korea

  • 2005
    AACR ITO-EN Scholar-In-Training Award, American Association for Cancer Research, USA

  • 2005
    Best Research Award, National Cancer Center, Korea

  • 2005
    GlaxoSmithKline (GSK) Award from Korean Cancer Association, Korea

  • 2006
    AACR ITO-EN Scholar-In-Training Award, American Association for Cancer Research, USA

  • 2008
    Impact Paper of the Year Award, The American Society of Colon and Rectal Surgeons, USA

  • 2012
    Uniting Against Lung Cancer Research Grant Award, Uniting Against Lung Cancer, USA

Selected Publications

  1. Whole exome and targeted deep sequencing identify genome-wide allelic loss and frequent SETDB1 mutations in malignant pleural mesotheliomas. Oncotarget. 2016 Jan 27.
    View on PubMed
  2. An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancer. Oncotarget. 2015 Sep 2.
    View on PubMed
  3. Genetic variation in the functional ENG allele inherited from the non-affected parent associates with presence of pulmonary arteriovenous malformation in hereditary hemorrhagic telangiectasia 1 (HHT1) and may influence expression of PTPN14. Front Genet. 2015; 6:67.
    View on PubMed
  4. CK2a, over-expressed in human malignant pleural mesothelioma, regulates the Hedgehog signaling pathway in mesothelioma cells. J Exp Clin Cancer Res. 2014; 33(1):93.
    View on PubMed
  5. Comprehensive genomic analyses of a metastatic colon cancer to the lung by whole exome sequencing and gene expression analysis. Int J Oncol. 2014 Jan; 44(1):211-21.
    View on PubMed
  6. Multistep Progression from Atypical Adenomatous Hyperplasia to Lung Adenocarcinoma: Clinico-Pathologic, Epigenetic and Genetic Aspects. J Surgery. 2013; 1(1):10.
    View on PubMed
  7. Targeting Gli transcription activation by small molecule suppresses tumor growth. Oncogene. 2014 Apr 17; 33(16):2087-97.
    View on PubMed
  8. Multiple self-healing squamous epithelioma (MSSE): rare variants in an adjacent region of chromosome 9q22.3 to known TGFBR1 mutations suggest a digenic or multilocus etiology. J Invest Dermatol. 2013 Jul; 133(7):1907-10.
    View on PubMed
  9. Rewiring of human lung cell lineage and mitotic networks in lung adenocarcinomas. Nat Commun. 2013; 4:1701.
    View on PubMed
  10. Gremlin is overexpressed in lung adenocarcinoma and increases cell growth and proliferation in normal lung cells. PLoS One. 2012; 7(8):e42264.
    View on PubMed
  11. A somatic TSHR mutation in a patient with lung adenocarcinoma with bronchioloalveolar carcinoma, coronary artery disease and severe chronic obstructive pulmonary disease. Oncol Rep. 2012 Oct; 28(4):1225-30.
    View on PubMed
  12. Inhibition of CK2a down-regulates Hedgehog/Gli signaling leading to a reduction of a stem-like side population in human lung cancer cells. PLoS One. 2012; 7(6):e38996.
    View on PubMed
  13. Pten regulates Aurora-A and cooperates with Fbxw7 in modulating radiation-induced tumor development. Mol Cancer Res. 2012 Jun; 10(6):834-44.
    View on PubMed
  14. Development of a rapid and practical mutation screening assay for human lung adenocarcinoma. Int J Oncol. 2012 Jun; 40(6):1900-6.
    View on PubMed
  15. Hipk2 cooperates with p53 to suppress ?-ray radiation-induced mouse thymic lymphoma. Oncogene. 2012 Mar 1; 31(9):1176-80.
    View on PubMed
  16. Network analysis of skin tumor progression identifies a rewired genetic architecture affecting inflammation and tumor susceptibility. Genome Biol. 2011; 12(1):R5.
    View on PubMed
  17. Deletion of the PER3 gene on chromosome 1p36 in recurrent ER-positive breast cancer. J Clin Oncol. 2010 Aug 10; 28(23):3770-8.
    View on PubMed
  18. Functional polymorphism of the CK2alpha intronless gene plays oncogenic roles in lung cancer. PLoS One. 2010; 5(7):e11418.
    View on PubMed
  19. Establishment and characterization of 13 human colorectal carcinoma cell lines: mutations of genes and expressions of drug-sensitivity genes and cancer stem cell markers. Carcinogenesis. 2010 Jun; 31(6):1003-9.
    View on PubMed
  20. Galectin-3 stabilizes heterogeneous nuclear ribonucleoprotein Q to maintain proliferation of human colon cancer cells. Cell Mol Life Sci. 2009 Jan; 66(2):350-64.
    View on PubMed

Go to UCSF Profiles, powered by CTSI